• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋天然产物的抗锥虫活性。

Trypanocidal activity of marine natural products.

机构信息

Eskitis Institute for Drug Discovery, Griffith University, Nathan, Brisbane 4111, Australia.

出版信息

Mar Drugs. 2013 Oct 22;11(10):4058-82. doi: 10.3390/md11104058.

DOI:10.3390/md11104058
PMID:24152565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3826150/
Abstract

Marine natural products are a diverse, unique collection of compounds with immense therapeutic potential. This has resulted in these molecules being evaluated for a number of different disease indications including the neglected protozoan diseases, human African trypanosomiasis and Chagas disease, for which very few drugs are currently available. This article will review the marine natural products for which activity against the kinetoplastid parasites; Trypanosoma brucei brucei, T.b. rhodesiense and T. cruzi has been reported. As it is important to know the selectivity of a compound when evaluating its trypanocidal activity, this article will only cover molecules which have simultaneously been tested for cytotoxicity against a mammalian cell line. Compounds have been grouped according to their chemical structure and representative examples from each class were selected for detailed discussion.

摘要

海洋天然产物是一类具有巨大治疗潜力的多样化、独特的化合物。这导致这些分子被评估用于许多不同的疾病适应症,包括被忽视的原生动物疾病、人类非洲锥虫病和恰加斯病,目前这些疾病几乎没有可用的药物。本文将综述针对动质体寄生虫;布氏锥虫布鲁斯、T.b.罗得西亚和克氏锥虫的具有活性的海洋天然产物。由于在评估其杀锥虫活性时了解化合物的选择性非常重要,因此本文仅涵盖已同时针对哺乳动物细胞系进行细胞毒性测试的分子。化合物已根据其化学结构进行分组,并选择每类的代表性实例进行详细讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/4b6ff5952dfb/marinedrugs-11-04058-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/c82be602caac/marinedrugs-11-04058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/fb7c192e5e94/marinedrugs-11-04058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/038b53c47b20/marinedrugs-11-04058-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/d7234dda3d14/marinedrugs-11-04058-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/b999533ba409/marinedrugs-11-04058-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/a86b1bef832c/marinedrugs-11-04058-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/d72df14cb0d1/marinedrugs-11-04058-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/9c0ebb550eae/marinedrugs-11-04058-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/f3e8cb924f55/marinedrugs-11-04058-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/4b6ff5952dfb/marinedrugs-11-04058-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/c82be602caac/marinedrugs-11-04058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/fb7c192e5e94/marinedrugs-11-04058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/038b53c47b20/marinedrugs-11-04058-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/d7234dda3d14/marinedrugs-11-04058-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/b999533ba409/marinedrugs-11-04058-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/a86b1bef832c/marinedrugs-11-04058-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/d72df14cb0d1/marinedrugs-11-04058-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/9c0ebb550eae/marinedrugs-11-04058-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/f3e8cb924f55/marinedrugs-11-04058-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b043/3826150/4b6ff5952dfb/marinedrugs-11-04058-g010.jpg

相似文献

1
Trypanocidal activity of marine natural products.海洋天然产物的抗锥虫活性。
Mar Drugs. 2013 Oct 22;11(10):4058-82. doi: 10.3390/md11104058.
2
Secondary metabolites from Vietnamese marine invertebrates with activity against Trypanosoma brucei and T. cruzi.来自越南海洋无脊椎动物的具有抗布氏锥虫和克氏锥虫活性的次生代谢产物。
Molecules. 2014 Jun 11;19(6):7869-80. doi: 10.3390/molecules19067869.
3
Trypanocidal Essential Oils: A Review.抗锥虫精油:综述。
Molecules. 2020 Oct 6;25(19):4568. doi: 10.3390/molecules25194568.
4
[Rational concepts and the study of active molecules against various trypanosomiases].[针对各种锥虫病的合理概念及活性分子研究]
Bull Soc Pathol Exot. 1994;87(5):353-61.
5
Applicability of plant-based products in the treatment of Trypanosoma cruzi and Trypanosoma brucei infections: a systematic review of preclinical in vivo evidence.植物基产品在治疗克氏锥虫和布氏锥虫感染中的适用性:对临床前体内证据的系统评价
Parasitology. 2017 Sep;144(10):1275-1287. doi: 10.1017/S0031182017000634. Epub 2017 Jun 5.
6
New leads for trypanosomiasis chemotherapy.锥虫病化疗的新线索。
Lancet. 1978 Dec 2;2(8101):1190.
7
In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.芳基取代咪唑衍生物作为抗原生动物药物的体外评价以及对克氏锥虫、婴儿利什曼原虫和布氏锥虫的甾醇14α-脱甲基酶(CYP51)的对接研究。
Parasitol Res. 2019 May;118(5):1533-1548. doi: 10.1007/s00436-019-06206-z. Epub 2019 Mar 23.
8
Trypanocidal drugs: mechanisms, resistance and new targets.抗锥虫药物:作用机制、耐药性及新靶点
Expert Rev Mol Med. 2009 Oct 29;11:e31. doi: 10.1017/S1462399409001252.
9
Multitask learning-driven identification of novel antitrypanosomal compounds.多任务学习驱动的新型抗锥虫化合物鉴定
Future Med Chem. 2023 Aug;15(16):1449-1467. doi: 10.4155/fmc-2023-0074. Epub 2023 Sep 13.
10
Screening a Natural Product-Based Library against Kinetoplastid Parasites.抗锥虫天然产物文库的筛选。
Molecules. 2017 Oct 12;22(10):1715. doi: 10.3390/molecules22101715.

引用本文的文献

1
Selective Antiproliferative and Apoptotic Effects of 2,6-Diketopiperazines on MDA-MB-231 Triple-Negative Breast Cancer.2,6-二酮哌嗪对MDA-MB-231三阴性乳腺癌的选择性抗增殖和凋亡作用
Chem Biol Drug Des. 2025 Apr;105(4):e70098. doi: 10.1111/cbdd.70098.
2
Exploring Marine Natural Compounds: Innovative Therapeutic Candidates Against Chagas Disease Through Virtual Screening and Molecular Dynamics.探索海洋天然化合物:通过虚拟筛选和分子动力学寻找治疗恰加斯病的创新候选药物。
Life (Basel). 2025 Jan 28;15(2):192. doi: 10.3390/life15020192.
3
Identification of Novel Flavonoids and Ansa-Macrolides with Activities against through Natural Product Library Screening.

本文引用的文献

1
Synthesis of marine-derived 3-alkylpyridinium alkaloids with potent antiprotozoal activity.具有强效抗原生动物活性的海洋源3-烷基吡啶生物碱的合成。
ACS Med Chem Lett. 2011 Oct 5;2(12):901-6. doi: 10.1021/ml200160k. eCollection 2011 Dec 8.
2
Approaches to protozoan drug discovery: phenotypic screening.原生动物药物发现方法:表型筛选。
J Med Chem. 2013 Oct 24;56(20):7727-40. doi: 10.1021/jm4004279. Epub 2013 Aug 20.
3
In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
通过天然产物库筛选鉴定具有抗……活性的新型黄酮类化合物和安莎大环内酯类化合物。 (原文中“against”后缺少具体对象)
Pathogens. 2024 Feb 28;13(3):213. doi: 10.3390/pathogens13030213.
4
Synthesis and Evaluation of Marine-Inspired Compounds Result in Hybrids with Antitrypanosomal and Antileishmanial Activities.海洋源灵感化合物的合成与评价导致具有抗锥虫和抗利什曼原虫活性的杂种。
Mar Drugs. 2023 Oct 24;21(11):551. doi: 10.3390/md21110551.
5
Piplartine-Inspired 3,4,5-Trimethoxycinnamates: Trypanocidal, Mechanism of Action, and In Silico Evaluation.胡椒烷型 3,4,5-三甲氧基肉桂酸酯类化合物的抗锥虫作用、作用机制及计算机模拟评价
Molecules. 2023 Jun 2;28(11):4512. doi: 10.3390/molecules28114512.
6
Antimicrobial Peptides (AMPs): Potential Therapeutic Strategy against Trypanosomiases?抗菌肽(AMPs):抗锥虫病的潜在治疗策略?
Biomolecules. 2023 Mar 26;13(4):599. doi: 10.3390/biom13040599.
7
In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against .用于治疗的潜在新型化合物UBMC - 4的计算机模拟、体外及药代动力学研究
Pathogens. 2022 May 24;11(6):616. doi: 10.3390/pathogens11060616.
8
Recent Advances in the Discovery of Novel Antiprotozoal Agents.新型抗寄生虫药物的研究进展。
Molecules. 2019 Oct 28;24(21):3886. doi: 10.3390/molecules24213886.
9
Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological Systems.对抗利什曼病和恰加斯病的治疗干预措施:从传统来源到纳米技术系统
Pathogens. 2019 Aug 1;8(3):119. doi: 10.3390/pathogens8030119.
10
Spiralyde A, an Antikinetoplastid Dolabellane from the Brown Alga .螺旋藻 A,一种来自褐藻的抗锥虫多贝拉烷
Mar Drugs. 2019 Mar 25;17(3):192. doi: 10.3390/md17030192.
体外和体内研究抗寄生虫药甾醇 14α-去甲基酶(CYP51)抑制剂 VNI 对克氏锥虫耐药株的抗寄生虫活性。
Antimicrob Agents Chemother. 2013 Sep;57(9):4151-63. doi: 10.1128/AAC.00070-13. Epub 2013 Jun 17.
4
Whole-organism high-throughput screening against Trypanosoma brucei brucei.针对布氏冈比亚锥虫的全生物体高通量筛选。
Expert Opin Drug Discov. 2013 May;8(5):495-507. doi: 10.1517/17460441.2013.783816. Epub 2013 Mar 31.
5
Examination of the mode of action of the almiramide family of natural products against the kinetoplastid parasite Trypanosoma brucei.研究阿米酰胺类天然产物对克氏锥虫的作用模式。
J Nat Prod. 2013 Apr 26;76(4):630-41. doi: 10.1021/np300834q. Epub 2013 Feb 27.
6
Marine natural products.海洋天然产物。
Nat Prod Rep. 2013 Feb;30(2):237-323. doi: 10.1039/c2np20112g.
7
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.291 种疾病和伤害导致的伤残调整生命年(DALYs)在 21 个地区,1990-2010 年:全球疾病负担研究 2010 的系统分析。
Lancet. 2012 Dec 15;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4.
8
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
9
Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.基于全细胞活力测定的高通量筛选方法鉴定具有抗布氏锥虫 427 株增殖活性的化合物。
PLoS Negl Trop Dis. 2012;6(11):e1896. doi: 10.1371/journal.pntd.0001896. Epub 2012 Nov 29.
10
Brentuximab vedotin.本妥昔单抗维迪西妥单抗。
Clin Cancer Res. 2013 Jan 1;19(1):22-7. doi: 10.1158/1078-0432.CCR-12-0290. Epub 2012 Nov 15.